Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2002 6
2003 2
2004 3
2005 1
2006 5
2007 5
2008 7
2009 9
2010 9
2011 11
2012 11
2013 11
2014 12
2015 7
2016 12
2017 12
2018 15
2019 18
2020 23
2021 26
2022 27
2023 17
2024 23
2025 23
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

272 results

Results by year

Filters applied: . Clear all
Page 1
Emergent HIV drug resistance in non-inferiority trials.
Ripamonti D, Zazzi M. Ripamonti D, et al. Among authors: zazzi m. Lancet HIV. 2023 Oct;10(10):e632-e634. doi: 10.1016/S2352-3018(23)00203-5. Epub 2023 Sep 12. Lancet HIV. 2023. PMID: 37714175 No abstract available.
Pillars of long-term antiretroviral therapy success.
Taramasso L, Andreoni M, Antinori A, Bandera A, Bonfanti P, Bonora S, Borderi M, Castagna A, Cattelan AM, Celesia BM, Cicalini S, Cingolani A, Cossarizza A, D'Arminio Monforte A, D'Ettorre G, Di Biagio A, Di Giambenedetto S, Di Perri G, Esposito V, Focà E, Gervasoni C, Gori A, Gianotti N, Guaraldi G, Gulminetti R, Lo Caputo S, Madeddu G, Maggi P, Marandola G, Marchetti GC, Mastroianni CM, Mussini C, Perno CF, Rizzardini G, Rusconi S, Santoro M, Sarmati L, Zazzi M, Maggiolo F. Taramasso L, et al. Among authors: zazzi m. Pharmacol Res. 2023 Oct;196:106898. doi: 10.1016/j.phrs.2023.106898. Epub 2023 Aug 28. Pharmacol Res. 2023. PMID: 37648103 Free article. Review.
Combined doravirine and islatravir cooperate to inhibit NRTI and NNRTI resistant HIV-1 in vitro.
Giammarino F, Paletti C, Bartolini N, Fiaschi L, Biba C, Varasi I, Focà E, Gulminetti R, Ferrara M, Comi L, Vicenti I, Castagna A, Zazzi M, Saladini F; PRESTIGIO Study Group. Giammarino F, et al. Among authors: zazzi m. Antiviral Res. 2025 Jul;239:106157. doi: 10.1016/j.antiviral.2025.106157. Epub 2025 Apr 18. Antiviral Res. 2025. PMID: 40254262 Free article.
Spectrum of Atazanavir-Selected Protease Inhibitor-Resistance Mutations.
Rhee SY, Boehm M, Tarasova O, Di Teodoro G, Abecasis AB, Sönnerborg A, Bailey AJ, Kireev D, Zazzi M, The EuResist Network Study Group, Shafer RW. Rhee SY, et al. Among authors: zazzi m. Pathogens. 2022 May 5;11(5):546. doi: 10.3390/pathogens11050546. Pathogens. 2022. PMID: 35631067 Free PMC article.
Genomic Epidemiology of the Main SARS-CoV-2 Variants Circulating in Italy During the Omicron Era.
Bergna A, Lai A, Sagradi F, Menzo S, Mancini N, Bruzzone B, Rusconi S, Marchegiani G, Clementi N, Francisci D, Vicenti I, Ronchiadin S, Mbissam HD, Della Ventura C, Lanfranchi L, Testa S, Caucci S, Acciarri C, Carioti L, Occhionero A, Novazzi F, Genoni AP, Ferrante FD, De Pace V, Ferraris M, Ogliastro M, Gabrieli A, De Paschale M, Canavesi G, Bellocchi MC, Iannetta M, Sarmati L, Ceccherini-Silberstein F, Riva A, Antinori S, Zehender G; SARS‐CoV‐2 ITALIAN RESEARCH ENTERPRISE – collaborative Group. Bergna A, et al. J Med Virol. 2025 Feb;97(2):e70215. doi: 10.1002/jmv.70215. J Med Virol. 2025. PMID: 39936851 Free PMC article.
Inflammation burden score in multidrug-resistant HIV-1 infection.
Clemente T, Caccia R, Galli L, Galli A, Poli A, Marchetti GC, Bandera A, Zazzi M, Santoro MM, Cinque P, Castagna A, Spagnuolo V; PRESTIGIO Study Group. Clemente T, et al. Among authors: zazzi m. J Infect. 2023 May;86(5):453-461. doi: 10.1016/j.jinf.2023.03.011. Epub 2023 Mar 11. J Infect. 2023. PMID: 36913985
Evaluation of HIV-1 DNA resistance evolution in highly treatment-experienced and multi-resistant individuals under suppressive antiretroviral therapy: a longitudinal study from the PRESTIGIO Registry.
Armenia D, Marchegiani G, Spagnuolo V, Bellocchi MC, Galli L, Clemente T, Carioti L, Lolatto R, Ferrara M, Gagliardini R, Marchetti GC, Torti C, De Socio G, Fornabaio C, Zazzi M, Castagna A, Santoro MM; PRESTIGIO Study Group. Armenia D, et al. J Antimicrob Chemother. 2025 Nov 4;80(11):3101-3106. doi: 10.1093/jac/dkaf349. J Antimicrob Chemother. 2025. PMID: 40990139 Free PMC article.
Comparison of diagnostic performances of HDV-RNA quantification assays used in clinical practice: Results from a national quality control multicenter study.
Salpini R, Piermatteo L, Caviglia GP, Bertoli A, Brunetto MR, Bruzzone B, Callegaro A, Caudai C, Cavallone D, Chessa L, Coghe F, Coppola N, Cuomo N, D'Anna S, Di Stefano M, Facchetti F, Farina C, Ferraro D, Franchin E, Francisci D, Galli S, Garbuglia AR, Gennari W, Ghisetti V, Lampertico P, Lo Caputo S, Marascio N, Menzo S, Micheli V, Niro GA, Olivero A, Paba P, Palermo CI, Palmieri O, Paolucci S, Pisaturo M, Pollicino T, Raffa G, Santantonio T, Torre G, Turriziani O, Uzzau S, Uceda Renteria SC, Vatteroni M, Zazzi M, Craxì A, Ceccherini-Silberstein F, Svicher V; HCV Virology Italian Resistance Network (VIRONET-C); Arosio M, Bastianelli S, Gentile A, Giardina FAM, Gidari A, Govoni R, Ibba G, Loglio A, Lombardi A, Mascarella C, Maggi F, Matera G, Mazzei C, Milia MG, Quirino A, Raddi A, Scioscia R, Tagliazucchi S, Totaro M, Valaperta R. Salpini R, et al. Among authors: zazzi m. J Clin Virol. 2025 Oct;180:105850. doi: 10.1016/j.jcv.2025.105850. Epub 2025 Aug 6. J Clin Virol. 2025. PMID: 40784197 Free article.
272 results